Etiometry Expands its Clinical Decision-Support Software with a NICU Focus
News and Press Releases
BOSTON, September 1st, 2020 – Etiometry, Inc., the leader in clinical decision-support software for the intensive care environment, is expanding their efforts into neonatal intensive care units. The announcement comes as Etiometry recognizes the work and dedication of clinicians improving the health of the most vulnerable patients during NICU Awareness Month, which kicks-off today.
Advancements in monitoring and support technologies have aided clinicians in improving the care they deliver and the impact they have had in improving the health and outcomes of NICU patients. Etiometry is focused on delivering technologies to further aid NICU clinicians in identifying and managing patients at risk of hemodynamic and respiratory instability to avoid complications and speed recovery.
WATCH THIS: Etiometry Supporting NICU Initiatives
“These are arguably the most delicate patients to treat and we do not take that responsibility lightly. The Etiometry Platform provides clinicians with easy access and visibility to available patient data when and where it is needed for critical decision support, as well as determining the progress of the patient’s condition,” explained Etiometry’s CEO, Shane Cooke.
The Etiometry Platform harnesses patient data to create novel risk indices for clinicians to better identify trending stages of clinical deterioration to improve the quality of care and health of individual patients. Etiometry is the first company to earn FDA-clearance for two critical care risk indices for patients under 12 years old.
NICU Awareness Month was created to celebrate the clinicians who take care of the tiniest patients and the families who never leave their side during a difficult journey. To support NICU Awareness Month, please join Etiometry in wearing green and using the hashtag #NICUAwarenessMonth.
About Etiometry
Etiometry Inc. is the leader in clinical decision-support software for the intensive care environment. Our technologies provide valuable clinical insight and analysis to support early recognition of subtle changes in patient condition to avoid complications and speed recovery. Etiometry is committed to improving patient outcomes, increasing clinical efficiency, and lowering costs of care through the more effective use of all available data.
For more information, visit www.etiometry.com
Related
First Automated Hospital-Specific Cardiogenic Shock Classification Tool for Critical Care Teams
Etiometry has received FDA clearance (K254066) for the Etiometry Cardiogenic Shock Tool: the first-ever automated solution for hospital-specific cardiogenic shock classification and tracking (aligned with each institution’s own protocols) using physiologic monitoring data. This is Etiometry’s 11th FDA clearance overall, and the only solution that automates SCAI staging directly from physiologic monitoring data. For cardiac […]
The Business Case for Clinical Intelligence in the ICU. Is it a Worthwhile Investment?
Hospital operating margins remain thin and ICU cost is one of the largest line items in any high-acuity hospital. Clinical intelligence software, used as adjunctive support for clinician-directed care, has been associated with shorter ICU length of stay, fewer unplanned readmissions, and reduced ventilation time. Despite this, many senior hospital leaders are unsure of the […]
What is Clinical Intelligence Software and is it Ready for Clinical Reality?
ICU environments generate high volumes of physiologic data and alerts. “Alarm fatigue” is well documented in the literature, and it is linked to desensitisation, missed deterioration signals, and worse patient outcomes1. Clinical intelligence software can help here. It processes patient data continuously and highlights the risk signals that clinicians have defined as important, so teams […]